David Ho

University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
"David Ho"


Sign in to add trainee
Alan M Jones grad student 1982-1983 UIUC
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Purpura LJ, Chang M, Annavajhala MK, et al. (2021) Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
King HAD, Joyce MG, Lakhal-Naouar I, et al. (2021) Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques. Proceedings of the National Academy of Sciences of the United States of America. 118
Mack CD, Tai C, Sikka R, et al. (2021) SARS-CoV-2 Reinfection: A Case Series from a 12-Month Longitudinal Occupational Cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America
Annavajhala MK, Mohri H, Wang P, et al. (2021) Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York. Nature
Yang L, Nilsson-Payant BE, Han Y, et al. (2021) Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2. Stem Cell Reports
Kissler SM, Fauver JR, Mack C, et al. (2021) Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies. Plos Biology. 19: e3001333
Ke R, Zitzmann C, Ho DD, et al. (2021) In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness. Medrxiv : the Preprint Server For Health Sciences
Cerutti G, Guo Y, Wang P, et al. (2021) Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain. Biorxiv : the Preprint Server For Biology
Cerutti G, Rapp M, Guo Y, et al. (2021) Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies. Structure (London, England : 1993)
Xu J, Xu K, Jung S, et al. (2021) Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature
See more...